Small Molecules

14 Feb 2007 Pfizer's Maraviroc to Receive Accelerated Regulatory Reviews in the U.S. and Europe
14 Feb 2007 InSite Vision Announces Positive Top-Line Safety Results from Phase 1 AzaSite Plus Clinical Study
14 Feb 2007 Further Validation of NNZ-2566 as a Traumatic Brain Injury Treatment
14 Feb 2007 Somaxon Provides Update on SILENOR(TM) Preclinical Program
14 Feb 2007 SIGA Begins Second Human Safety Trial of Its Lead Smallpox Drug
14 Feb 2007 BioLineRx Successfully Completes Phase 1 Clinical Trials of BL-1020, First in Class GABA-Enhanced Antipsychotic for the Treatment of Schizophrenia
14 Feb 2007 Dynogen Reports Positive Results in Phase 2 IBS-c Study
14 Feb 2007 Elixir Pharmaceuticals and Siena Biotech S.p.A. Enter Agreement to Evaluate SIRT1 Inhibitors in Huntington's Disease
14 Feb 2007 Poniard Pharmaceuticals Files Investigational New Drug Application for Oral Formulation of Picoplatin
13 Feb 2007 Adolor Corporation Initiates Phase 1 Multi-Dose Study of Novel Delta Opioid Agonist for the Management of Pain
13 Feb 2007 Nexavar Shown to Significantly Extend Survival for Patients with Advanced Liver Cancer
13 Feb 2007 NicOx presents promising pre-clinical results on an NOdonating latanoprost derivative from its glaucoma collaboration with Pfizer
13 Feb 2007 ZIOPHARM Presents ZIO-101 Data at Bone Marrow Transplant Meeting
13 Feb 2007 Medivir Outlicenses The Antiviral Compound MIV-160 To Guangdong Lantai Viewland Pharmaceutical CO. LTD
13 Feb 2007 Rimonabant USA: Update
11 Feb 2007 Nuvo announces update on discussions with FDA related to approval of Pennsaid
10 Feb 2007 Anesiva Presents Data On Pain Drug, 4975, Demonstrating Pain Reduction For Up To Two Weeks After Knee Replacement Surgeries
10 Feb 2007 FibroGen Reports Pharmacologic Stabilization of Hypoxia-Inducible Factor (HIF) Prevents Brain Tissue Damage and Preserves Motor Function in a Preclinical Model of Transient Ischemic Stroke
09 Feb 2007 Clinical Phase I Trial With Hepatitis C Virus Protease Inhibitor Initiated
09 Feb 2007 GlaxoSmithKline and XenoPort announce agreement on late-stage compound for RLS and neuropathic pain
09 Feb 2007 DAIICHI SANKYO returns development rights of KAI-9803
09 Feb 2007 Results of Inhaled Treprostinil Controlled Pilot Studies Reported in the Journal of the American College Of Cardiology
09 Feb 2007 ISTA Pharmaceuticals Announces Positive Preliminary Xibrom(TM) Once-daily Formulation Clinical Results From U.S. Phase III Trials
09 Feb 2007 GlaxoSmithKline and Fabre-Kramer Pharmaceuticals enter global agreement for new treatment of major depressive disorder
09 Feb 2007 SRI International and Telik Announce Exclusive License for SRI to Develop Autoimmune and Inflammatory Disease Drug Candidate

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2020 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up